Alison Birtle, MD, joins the podcast to provide an update on the POUT trial, which analyzed the use of adjuvant chemotherapy after nephroureterectomy for patients with upper tract urothelial cancer.
Dr. Birtle serves as Consultant Clinical Oncologist for Lancashire Teaching Hospitals NHS Foundation Trust.